# FDA Inspection 1101579 - Nalpropion Pharmaceuticals, Inc. - August 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/nalpropion-pharmaceuticals-inc/57f05d69-5b0b-447d-b7d1-4b6ebaf382b1
Source feed: FDA_Inspections

> FDA Inspection 1101579 for Nalpropion Pharmaceuticals, Inc. on August 16, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101579
- Company Name: Nalpropion Pharmaceuticals, Inc.
- Inspection Date: 2019-08-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 678985 - 2010-09-02](https://www.keypedia.com/records/fda_inspections/nalpropion-pharmaceuticals-inc/2408d1be-d007-4cb2-a49a-4964b55fd15b)

Company: https://www.keypedia.com/companies/nalpropion-pharmaceuticals-inc/3b6dd4c5-c0fa-4d82-96c9-723f107b1844

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c